Biotechnology Portfolio  |  Medical Technology Portfolio | Healthcare IT Portfolio

Avid Radiopharmaceuticals
Location:  Philadelphia, PA

Avid is a clinical-stage product-focused molecular imaging company with signficant expertise and IP in the field of molecular brain imaging. Avid has developed proprietary targeting agents to image amyloid plaques and is currently testing these compounds in clinical trials for the detection of Alzheimer's disease. Avid has demonstrated the proof of mechanism in human trials with these agents. The Avid team is also developing novel agents targeted to the vesicular monoamine transporter (VMAT-2) to image pathology in dementia with Lewy bodies, Parkinson's disease, and has recently started a research project in diabetes mellitus. These agents have the potential to revolutionize early diagnosis and monitoring of disease.

Other investors include: AllianceBernstein, BioAdvance, Pfizer Strategic Investment Group, RK Ventures, and Safeguard Scientifics.

Remon Medical Technologies (acquired by Boston Scientific Corporation, BSX: NYSE)
Location:  Caesaria, Israel

Remon Medical Technologies develops and commercializes smart, miniature implants which enable physicians to assess and treat a variety of medical conditions in a non-invasive manner.  The Company's enabling technology utilizes wireless communications to exchange energy and data with minute devices placed deep inside the body.  These devices either monitor a variety of physiological parameters or stimulate tissues and organs, or activate other devices, creating therapeutic responses.  Remon's unique platform has broad applications for patient management, post-operative monitoring, nerve and tissue stimulation, local drug delivery and drug development.  The Company is developing two initial products that address growing needs in the cardiology and vascular surgery markets.

Other investors include: Concord Ventures, KBL Healthcare Ventures, Ofer Hi-Tech Group and Polaris Venture Partners.